[
  {
    "ts": null,
    "headline": "Eli Lilly (NYSE:LLY) Collaborates With Juvena To Enhance Muscle Health Through AI Technology",
    "summary": "Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore AI-driven drug candidates for muscle health. This innovative move, alongside other significant developments like the Cialis acquisition in Latin America, underscores the company's commitment to expanding its product portfolio and reaching new markets. Over the past month, Eli Lilly's stock rose by nearly 10%, a performance that aligns with the broader upward trend of...",
    "url": "https://finnhub.io/api/news?id=4b4da3ae28d63edcbbade8cca49524b1b828c942042ec978b67c4f7fbe97604e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749663515,
      "headline": "Eli Lilly (NYSE:LLY) Collaborates With Juvena To Enhance Muscle Health Through AI Technology",
      "id": 135192564,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore AI-driven drug candidates for muscle health. This innovative move, alongside other significant developments like the Cialis acquisition in Latin America, underscores the company's commitment to expanding its product portfolio and reaching new markets. Over the past month, Eli Lilly's stock rose by nearly 10%, a performance that aligns with the broader upward trend of...",
      "url": "https://finnhub.io/api/news?id=4b4da3ae28d63edcbbade8cca49524b1b828c942042ec978b67c4f7fbe97604e"
    }
  },
  {
    "ts": null,
    "headline": "Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel",
    "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, “Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agenci",
    "url": "https://finnhub.io/api/news?id=0fb2c9884a3d968b1b0c30f15e468bdc5f7226238ff1a399f8ca9a402bd38ad7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749651653,
      "headline": "Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel",
      "id": 135184593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, “Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agenci",
      "url": "https://finnhub.io/api/news?id=0fb2c9884a3d968b1b0c30f15e468bdc5f7226238ff1a399f8ca9a402bd38ad7"
    }
  },
  {
    "ts": null,
    "headline": "Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?",
    "summary": "LLY banks on soaring Mounjaro and Zepbound sales to defend its obesity edge amid intensifying competition.",
    "url": "https://finnhub.io/api/news?id=6a00ce269d09b17d72898cf61aae02aa7ef8e67d31d9cf2c623c605c476d1d62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749649080,
      "headline": "Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?",
      "id": 135191293,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "LLY banks on soaring Mounjaro and Zepbound sales to defend its obesity edge amid intensifying competition.",
      "url": "https://finnhub.io/api/news?id=6a00ce269d09b17d72898cf61aae02aa7ef8e67d31d9cf2c623c605c476d1d62"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to",
    "summary": "Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.",
    "url": "https://finnhub.io/api/news?id=de17cb933d5052c727fb5fd53fccda5bcee6f2284641dd9e72c09120c77b4256",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749648773,
      "headline": "Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to",
      "id": 135179990,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.",
      "url": "https://finnhub.io/api/news?id=de17cb933d5052c727fb5fd53fccda5bcee6f2284641dd9e72c09120c77b4256"
    }
  },
  {
    "ts": null,
    "headline": "Juvena Therapeutics and Eli Lilly and Company Enter Research Collaboration Focused on Muscle Health",
    "summary": "Juvena Therapeutics, Inc. announced it has entered a global licensing and multi-target research collaboration with Eli Lilly and Company to discover, develop, and commercialize drug candidates that...",
    "url": "https://finnhub.io/api/news?id=c2098824e53111721adcd98235bb7d2a0d2348c35712fbf0e106ba6e742df7eb",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749631842,
      "headline": "Juvena Therapeutics and Eli Lilly and Company Enter Research Collaboration Focused on Muscle Health",
      "id": 135179251,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Juvena Therapeutics, Inc. announced it has entered a global licensing and multi-target research collaboration with Eli Lilly and Company to discover, develop, and commercialize drug candidates that...",
      "url": "https://finnhub.io/api/news?id=c2098824e53111721adcd98235bb7d2a0d2348c35712fbf0e106ba6e742df7eb"
    }
  },
  {
    "ts": null,
    "headline": "Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple",
    "summary": "Denmark's Novo Nordisk ispartnering with biotech company Deep Apple Therapeutics in adeal worth up to $812 million to develop drugs forcardiometabolic diseases, including obesity,...",
    "url": "https://finnhub.io/api/news?id=d0bc07ef6511a401738fd5613a22b46ae3594a81fcbd2ef025abaf00ef54906b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749631815,
      "headline": "Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple",
      "id": 135179239,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Denmark's Novo Nordisk ispartnering with biotech company Deep Apple Therapeutics in adeal worth up to $812 million to develop drugs forcardiometabolic diseases, including obesity,...",
      "url": "https://finnhub.io/api/news?id=d0bc07ef6511a401738fd5613a22b46ae3594a81fcbd2ef025abaf00ef54906b"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy Eli Lilly Stock Before June 22?",
    "summary": "Eli Lilly will be presenting data from studies on multiple GLP-1 drugs later this month.  Eli Lilly (NYSE: LLY) stock hasn't been doing too well this year, but that could change later this month.  If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs.",
    "url": "https://finnhub.io/api/news?id=9e72c8f348c992cb3376cc4a4cd3fa2379fffced38862af1835997a8a2dc2ab3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749630180,
      "headline": "Should You Buy Eli Lilly Stock Before June 22?",
      "id": 135179991,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly will be presenting data from studies on multiple GLP-1 drugs later this month.  Eli Lilly (NYSE: LLY) stock hasn't been doing too well this year, but that could change later this month.  If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs.",
      "url": "https://finnhub.io/api/news?id=9e72c8f348c992cb3376cc4a4cd3fa2379fffced38862af1835997a8a2dc2ab3"
    }
  },
  {
    "ts": null,
    "headline": "The cheap fat jabs sending big pharma into a frenzy",
    "summary": "For many Americans who tuned in to watch the Super Bowl earlier this year, it was a surprise to find themselves fat-shamed during the ad break.",
    "url": "https://finnhub.io/api/news?id=50b0d1adfa1418a86bd6f625c74d94100b1abdec1838b02a21e69624371ffaea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749626039,
      "headline": "The cheap fat jabs sending big pharma into a frenzy",
      "id": 135179992,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "For many Americans who tuned in to watch the Super Bowl earlier this year, it was a surprise to find themselves fat-shamed during the ad break.",
      "url": "https://finnhub.io/api/news?id=50b0d1adfa1418a86bd6f625c74d94100b1abdec1838b02a21e69624371ffaea"
    }
  },
  {
    "ts": null,
    "headline": "Health Rounds: Patients drop fewer pounds with weight-loss drugs in real world than in trials",
    "summary": "People who take weight-loss drugshoping to achieve the impressive results observed in largeclinical trials may need to adjust their expectations, a newstudy suggests. In a real-world...",
    "url": "https://finnhub.io/api/news?id=42396a616325a629db53381ca885f3876aaeb4b33b63a5bfc90668b36890c756",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749625273,
      "headline": "Health Rounds: Patients drop fewer pounds with weight-loss drugs in real world than in trials",
      "id": 135178364,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "People who take weight-loss drugshoping to achieve the impressive results observed in largeclinical trials may need to adjust their expectations, a newstudy suggests. In a real-world...",
      "url": "https://finnhub.io/api/news?id=42396a616325a629db53381ca885f3876aaeb4b33b63a5bfc90668b36890c756"
    }
  }
]